Holen Sie sich die Stockscreener-App
3.79
19.94%
0.63
Schlusskurs vom Vortag:
$3.16
Offen:
$4.21
24-Stunden-Volumen:
26.84M
Relative Volume:
268.90
Marktkapitalisierung:
$12.43M
Einnahmen:
$14.58M
Nettoeinkommen (Verlust:
$-12.57M
KGV:
-0.6673
EPS:
-5.68
Netto-Cashflow:
$-13.07M
1W Leistung:
+27.61%
1M Leistung:
+56.61%
6M Leistung:
-11.66%
1J Leistung:
+60.59%
1-Tages-Spanne:
$3.55
$4.68
1-Wochen-Bereich:
$2.8601
$4.68
52-Wochen-Spanne:
$1.97
$6.28
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Firmenname
Vivos Therapeutics Inc
Sektor
Branche
Telefon
(866)908-4867
Adresse
7921 SOUTHPARK PLAZA,, LITTLETON
Vergleichen Sie VVOS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
3.785 | 12.43M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
135.96 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.27 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
397.53 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.32 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.17 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Vivos Therapeutics Inc Aktie (VVOS) Neueste Nachrichten
Short Interest in Vivos Therapeutics, Inc. (NASDAQ:VVOS) Grows By 48.3% - Defense World
SP Manager LLC Intends to Engage with Vivos Therapeutics, Inc. - MarketScreener
Vivos Therapeutics, Inc: SCN Acquisition Closed; Key Step in Strategic Pivot - Smartkarma
Comparing Vivos (OTCMKTS:RDGL) & Anika Therapeutics (NASDAQ:ANIK) - Defense World
Vivos Therapeutics Acquires The Sleep Center of Nevada - TipRanks
Vivos Therapeutics (VVOS) Completes Acquisition of Nevada Sleep Center | VVOS Stock News - GuruFocus
Vivos acquires largest Nevada sleep center, secures $11 million funding By Investing.com - Investing.com South Africa
Vivos Therapeutics Finalizes Acquisition Of The Sleep Center Of Nevada - Nasdaq
Vivos acquires largest Nevada sleep center, secures $11 million funding - Investing.com
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada, Expanding OSA Diagnostic and Treatment Capabilities - Nasdaq
Vivos Takes Over 7-Location Sleep Center Empire, Transforms Business Model with $11M Backing - Stock Titan
Critical Contrast: QHSLab (OTCMKTS:USAQ) & Vivos Therapeutics (NASDAQ:VVOS) - Defense World
vivos therapeutics appoints baker tilly as new auditor following merger - Investing.com Australia
vivos therapeutics appoints baker tilly as new auditor following merger By Investing.com - Investing.com India
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Drop in Short Interest - Defense World
Sleep Apnea Oral Appliances MarketGlobal Forecast to - GlobeNewswire
Vivos Therapeutics (NASDAQ:VVOS) Cut to Sell at Wall Street Zen - Defense World
Vivos Therapeutics (NASDAQ:VVOS) Stock Rating Lowered by Alliance Global Partners - Defense World
Sector Update: Health Care - marketscreener.com
Vivos Issues $1.1 Million Convertible Promissory Note - marketscreener.com
Vivos Therapeutics Secures $1.1M Convertible Note - TipRanks
Vivos Therapeutics (NASDAQ:VVOS) Cut to “Hold” at Alliance Global Partners - Defense World
Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 - MSN
Vivos Therapeutics (VVOS) Downgraded Amidst Business Model Challenges | VVOS Stock News - GuruFocus
Vivos Therapeutics (VVOS) Downgraded Amidst Business Model Chall - GuruFocus
Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today - MSN
Vivos Therapeutics’ Earnings Call: Strategic Shifts Amid Financial Challenges - TipRanks
Vivos Therapeutics Shifts Strategy Amid Financial Results - TipRanks
Earnings call transcript: Vivos Therapeutics reports Q1 2025 earnings, stock rises - Investing.com Nigeria
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates - sharewise
Vivos Therapeutics Q1 2025 Financial Results - TradingView
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - The Manila Times
Vivos Therapeutics Transforms Business Model with $9M Sleep Center Deal as Product Sales Rise - Stock Titan
Vivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Precision Radionuclide Therapy™ - GlobeNewswire
Vivos to Report First Quarter Results - Dentistry Today
Vivos Therapeutics Schedules Release of First Quarter 2025 Financial Results and Conference Call - The Manila Times
Vivos Therapeutics, Inc. to Release First Quarter 2025 Financial Results on May 15, 2025 - Nasdaq
Sleep Apnea Tech Leader Vivos Therapeutics Reports Q1 2025 Earnings TomorrowKey Details Here - Stock Titan
Vivos Therapeutics (VVOS) to Release Quarterly Earnings on Tuesday - Defense World
Vivos Therapeutics Inc expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - MSN
Geode Capital Management LLC Grows Stock Holdings in Vivos Therapeutics, Inc. (NASDAQ:VVOS) - Defense World
Veterinary Cancer Breakthrough: Vivos Reports 150% Growth, Expands Novel Treatment to Horses - Stock Titan
In brief: Revelstoke recaps AOM, Vivos to make buy, state legislation makes tracks - HME News
Healthcare Stocks Take A Hit Despite Abbott's Earnings Beat - Finimize
Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada - MSN
Vivos Therapeutics to Acquire The Sleep Center of Nevada - marketscreener.com
Finanzdaten der Vivos Therapeutics Inc-Aktie (VVOS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.94%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):